Top 20 Multiple Sclerosis Drugs Market Report

Top 20 Multiple Sclerosis Drugs Market Analysis and Segment Forecasts To 2030

Published Date: May, 2025
Base Year for Estimate:
Report ID: GVR-MT-100324
Format: Electronic (PDF)
Historical Data:
Number of Pages: 150

Market Segmentation

Top 20 Multiple Sclerosis Drugs Product Outlook (Revenue, USD Million, 2018 - 2030)
- OCREVUS
- TECFIDERA
- VUMERITY
- AVONEX
- PLEGRIDY
- TYSABRI
- FAMPYRA
- KESIMPTA
- GILENYA
- COPAXONE
- AUBAGIO
- MAVENCLAD
- Rebif
- AMPYRA
- BETASERON
- ZEPOSIA
- MAYZENT
- Lemtrada
- Acthar Gel
- RAYOS
Top 20 Multiple Sclerosis Drugs Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Top 20 Multiple Sclerosis Drugs Market, by Product
    - OCREVUS
    - TECFIDERA
    - VUMERITY
    - AVONEX
    - PLEGRIDY
    - TYSABRI
    - FAMPYRA
    - KESIMPTA
    - GILENYA
    - COPAXONE
    - AUBAGIO
    - MAVENCLAD
    - Rebif
    - AMPYRA
    - BETASERON
    - ZEPOSIA
    - MAYZENT
    - Lemtrada
    - Acthar Gel
    - RAYOS
  - U.S.
    - U.S. Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - Canada
    - Canada Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - Mexico
    - Mexico Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
- Europe
  - Europe Top 20 Multiple Sclerosis Drugs Market, by Product
    - OCREVUS
    - TECFIDERA
    - VUMERITY
    - AVONEX
    - PLEGRIDY
    - TYSABRI
    - FAMPYRA
    - KESIMPTA
    - GILENYA
    - COPAXONE
    - AUBAGIO
    - MAVENCLAD
    - Rebif
    - AMPYRA
    - BETASERON
    - ZEPOSIA
    - MAYZENT
    - Lemtrada
    - Acthar Gel
    - RAYOS
  - UK
    - UK Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - Germany
    - Germany Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - France
    - France Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - Italy
    - Italy Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - Spain
    - Spain Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - Denmark
    - Denmark Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - Sweden
    - Sweden Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - Norway
    - Norway Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
- Asia Pacific
  - Asia Pacific Top 20 Multiple Sclerosis Drugs Market, by Product
    - OCREVUS
    - TECFIDERA
    - VUMERITY
    - AVONEX
    - PLEGRIDY
    - TYSABRI
    - FAMPYRA
    - KESIMPTA
    - GILENYA
    - COPAXONE
    - AUBAGIO
    - MAVENCLAD
    - Rebif
    - AMPYRA
    - BETASERON
    - ZEPOSIA
    - MAYZENT
    - Lemtrada
    - Acthar Gel
    - RAYOS
  - Japan
    - Japan Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - China
    - China Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - India
    - India Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - South Korea
    - South Korea Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - Australia
    - Australia Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - Thailand
    - Thailand Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
- Latin America
  - Latin America Top 20 Multiple Sclerosis Drugs Market, by Product
    - OCREVUS
    - TECFIDERA
    - VUMERITY
    - AVONEX
    - PLEGRIDY
    - TYSABRI
    - FAMPYRA
    - KESIMPTA
    - GILENYA
    - COPAXONE
    - AUBAGIO
    - MAVENCLAD
    - Rebif
    - AMPYRA
    - BETASERON
    - ZEPOSIA
    - MAYZENT
    - Lemtrada
    - Acthar Gel
    - RAYOS
  - Brazil
    - Brazil Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS
  - Argentina
    - Argentina Top 20 Multiple Sclerosis Drugs Market, by Product
      - OCREVUS
      - TECFIDERA
      - VUMERITY
      - AVONEX
      - PLEGRIDY
      - TYSABRI
      - FAMPYRA
      - KESIMPTA
      - GILENYA
      - COPAXONE
      - AUBAGIO
      - MAVENCLAD
      - Rebif
      - AMPYRA
      - BETASERON
      - ZEPOSIA
      - MAYZENT
      - Lemtrada
      - Acthar Gel
      - RAYOS

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.